News
06-07-2011, 02:51 AM
Celgene International SÃ*rl today announced that results from two investigator initiated studies including ABRAXANE, and bevacizumab in unresectable melanoma were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.
More... (http://www.news-medical.net/news/20110607/ABRAXANE-and-bevacizumab-clinical-studies-on-unresectable-melanoma-presented-at-ASCO-2011.aspx)
More... (http://www.news-medical.net/news/20110607/ABRAXANE-and-bevacizumab-clinical-studies-on-unresectable-melanoma-presented-at-ASCO-2011.aspx)